Genetic polymorphisms related to the renin–angiotensin–aldosterone system and response to antihypertensive drugs

By Taverne Kim   de Groot Mark   de Boer Anthonius   Klungel Olaf  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 4, 2010-04 ,pp. : 439-460

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of combination therapy with angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertension

By Redón Josep   Trenkwalder Peter RA   Barrios Vivencio  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 2, 2013-02 ,pp. : 155-164

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs which target the renin–angiotensin–aldosterone system

By Steckelings Ulrike Muscha   Paulis Ludovit   Unger Thomas   Bader Michael  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 619-630

Informa Healthcare

Access to resources Recommend Favorite

Current status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease

By Ashby Emma Louise   Kehoe Patrick G  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1229-1242

Informa Healthcare

Access to resources Recommend Favorite

The Role of Angiotensin Receptor Blocker and Calcium Channel Blocker Combination Therapy in Treating Hypertension: Focus on Recent Studies

By Chrysant Steven G.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 5, 2010-10 ,pp. : 315-320

Adis International

Access to resources Recommend Favorite